Transcode Therapeutics, Inc. (RNAZ)
Data as of , from SEC Form 4 filings.
See up to 3 months of RNAZ. The 7-day demo opens the 1M and 3M ranges and puts RNAZ on your watchlist.
Start 7-day demoLatest RNAZ insider trades
About Transcode Therapeutics, Inc. (RNAZ)
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
- BOSTON, MA
- 12
- 2021
- Nasdaq
https://www.transcodetherapeutics.comSEC filings for RNAZ on EDGAR
RNAZ Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 185,000 | |
| Other acquisition / disposition | 4 | 13,835,824 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
RNAZ insider transactions (Form 4)
52 Form 4 filings on record, the earliest from Aug 5, 2026, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Thomas A. Fitzgerald - Officer | Grant or award | Stock Option (right to buy) | 185,000 | $0.00 | - | |
| DEFJ, LLC - 10% Owner | Other | Common Stock | 11,813,859 | - footnote F1,F2 | - | |
| DEFJ, LLC - 10% Owner | Other | Common Stock | 2,020,582 | - footnote F1,F2 | - | |
| DEFJ, LLC - 10% Owner | Other | Series A Non-Voting Convertible Preferred Stock | 1,181 footnote F4 | $0.00 | - | |
| DEFJ, LLC - 10% Owner | Other | Series B Non-Voting Convertible Preferred Stock | 202.06 | $0.00 | - | |
| ||||||
RNAZ insider trading FAQ
What is the latest insider trade for RNAZ?
Transcode Therapeutics, Inc. (RNAZ) had 2 insider filings in the last 90 days, with the most recent on 11 September 2026. The full record for RNAZ runs to 2 Form 4 filings, the earliest from 5 August 2026. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying RNAZ stock?
No insider purchases of RNAZ were filed in the last 90 days.
How many insiders are selling RNAZ stock?
No insider sales of RNAZ were filed in the last 90 days.
Where can I see RNAZ SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects RNAZ Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
2The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Thomas A. Fitzgerald view on EDGAR
- - DEFJ, LLC view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where RNAZ's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow RNAZ with a 7-day demo
- RNAZ on your watchlist
- Every RNAZ Form 4 filing on record
- Up to 3 months of RNAZ price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
